Pain Medicine, Interventional Pain Medicine · Birmingham, AL
NPI
1225250335
Since 2007
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
619 19th St S, 804 Jefferson Tower
Birmingham, AL, 35249
Phone (205) 934-6007
Groups this clinician bills Medicare through
Medicare paid, 2024
$671K
71,204 services
Medicare patients, 2024
533
Average age 68
Drug cost, 2024
$1.2M
27,808 prescriptions
Company payments, 2025
$1,837
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ryan M Almeida was code J1010 (injection, methylprednisolone acetate, 1 mg), 57,962 times for 295 patients. In total Ryan M Almeida billed 71,204 services in 61 codes, and Medicare paid $671K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 57,962 | 295 | $0.10 | $5,869 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 2,115 | 250 | $0.11 | $224 |
| 99214 Office E&M - Established | Office | 1,949 | 434 | $87.19 | $170K |
| 80307 Drug Tests | Office | 803 | 357 | $57.35 | $46K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 717 | 321 | $153.46 | $110K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 659 | 39 | $0.09 | $59.34 |
| 62323 Nerve Block Injection - Back | Office | 324 | 171 | $167.91 | $54K |
| 77002 Imaging - Miscellaneous | Office | 198 | 85 | $77.42 | $15K |
| 20610 Joint Injection | Office | 193 | 81 | $49.25 | $9,505 |
| J1040 Injection, methylprednisolone acetate, 80 mg | Office | 190 | 149 | $7.18 | $1,365 |
| 62321 Nerve Block Injection - Back | Office | 139 | 69 | $169.56 | $24K |
| 27096 Joint Injection | Office | 131 | 70 | $145.96 | $19K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 127 | 102 | $422.86 | $54K |
| 64493 Nerve Block Injection - Back | Office | 120 | 67 | $180.76 | $22K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 118 | 96 | $245.42 | $29K |
By year: 2022 $656K for 18,220 services; 2023 $791K for 13,939 services; 2024 $671K for 71,204 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 803 | 357 | $57.35 | $46K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 717 | 321 | $153.46 | $110K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 51 | 38 | $73.39 | $3,743 |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 43 | 39 | $194.77 | $8,375 |
Medicare prescription drug claims, 2024
In 2024, the drug Ryan M Almeida prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 6,596 prescriptions and refills. In total Ryan M Almeida wrote 27,808 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 6,596 | 6,609 | 886 | $145K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 5,398 | 5,399 | 704 | $138K |
| Gabapentin Generic | 3,893 | 3,943 | 563 | $41K |
| Tizanidine Hcl Generic | 1,810 | 1,867 | 281 | $15K |
| Cyclobenzaprine Hcl Generic | 1,770 | 1,776 | 274 | $14K |
| Pregabalin Generic | 1,631 | 1,654 | 242 | $37K |
| Methocarbamol Generic | 849 | 851 | 174 | $9,601 |
| Tramadol Hcl Generic | 557 | 558 | 131 | $4,294 |
| Lidocaine Generic | 502 | 516 | 99 | $37K |
| Acetaminophen-Codeine Acetaminophen With Codeine | 416 | 416 | 118 | $5,497 |
| Baclofen Generic | 361 | 367 | 62 | $3,011 |
| Morphine Sulfate Er Morphine Sulfate | 301 | 301 | 37 | $7,728 |
| Oxycodone Hcl Generic | 294 | 294 | 73 | $3,299 |
| Diclofenac Sodium Generic | 291 | 299 | 66 | $9,070 |
| Trazodone Hcl Generic | 269 | 271 | 62 | $876 |
Brand drugs: 1,122 claims; generic drugs: 26,686 claims; opioid claims: 14,483.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ryan M Almeida $1,837 ($1,837 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbott Laboratories with $968.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 43 | $968 |
| Boston Scientific Corporation BSX | 38 | $531 |
| Saluda Medical Americas, Inc. | 2 | $96.9 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $79.1 |
| Forte Bio-Pharma LLC | 2 | $59.69 |
| MML US, Inc. | 1 | $36.84 |
| Globus Medical, Inc. GMED | 1 | $29.63 |
| Vertex Pharmaceuticals Incorporated VRTX | 1 | $18.45 |
| Axsome Therapeutics, Inc. AXSM | 1 | $17.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.